GW Pharmaceuticals plc to Report Financial Results and Operational Progress for the Period Ending March 31, 2019 and Host Conference Call on May 6, 2019
Conference call information will be provided in the financial results press release.
Read More
Select Page
Apr 23, 2019 | 0
Conference call information will be provided in the financial results press release.
Read MoreApr 22, 2019 | 0
In its 2018 financial statement, the company reported over $1.2 million in revenue for year-end December 31, 2018 with over $500,000 in net profit.
Read MoreApr 18, 2019 | 0
Hemp, Inc. showed over an 1,800% increase in sales from previous year 2017.
Read MoreApr 17, 2019 | 0
The company’s largest shareholder made a selfless decision to show their belief in the future of the Company by selling shares back to MJ Holdings, Inc. at their original cost, which enabled the company to resell some of those shares for more than $5,000,000 without any dilution to its existing shareholders.
Read MoreApr 17, 2019 | 0
Fourth Quarter 2018: 118% Year-Over-Year Revenue GrowthFiscal 2018: 95% Revenue Year-Over-Year Growth; Adjusted EBITDA up 53%Strategic Investments Position MariMed for Dynamic Growth in Cannabis and Hemp CBD.
Read MoreApr 16, 2019 | 0
Management attributes the more than 350% revenue growth to the success of the company’s EVERx CBD Sports Beverage.
Read MoreApr 16, 2019 | 0
Management attributes the more than 350% revenue growth in 2018 from the less than $300,000 in revenue reported in 2017 to the success of the company’s EVERx CBD Sports Beverage.
Read MoreApr 9, 2019 | 0
Total revenue for the fourth quarter of 2018 increased 237% year-over-year to $20.8 million.
Read MoreApr 9, 2019 | 0
Aleafia Health will announce its 2018 Financial Results on April 29, 2019 at 7:00 a.m. EDT.
Read MoreApr 3, 2019 | 0
The audited consolidated financial statements and management’s discussion and analysis for the periods are available on SEDAR.
Read MoreGet stock alerts, news & related alerts straight to your inbox!